Quality of Life in Chinese Working and School Age Population With MDD

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-04-01

Study Completion Date

2021-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Major depressive disorder (MDD) is a common mental illness with high prevalence and global burden. Previous studies revealed that over 70% patients in remission still had decreased quality of life, severe function impairment, low positive mental health score and poor coping ability. However, few studies focus on working and school age patients with MDD. A GBD survey showed that over 40% MDD patients are 15-50 years old. Therefore, we initiate the present multi-center cross-sectional survey to investigate the associations between clinical symptoms, cognitive function, occupational/study ability, and quality of life in Chinese working and school age population with MDD who are in remission.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Objective Diagnostic Markers and Personalized Intervention in MDD Patients

NCT02023567

Depressive Disorder, Major

UNKNOWN NA

Multi-Dimensional Diagnosis,Individualized Therapy,and Management Technique for Major Depressive Disorder:Based on Clinical and Pathological Characteristics

NCT03219008

Depressive Disorder

UNKNOWN PHASE4

Optimization of Diagnosis and Treatment of Depression Based on Multidimensional Clinical Assessment Classification

NCT04528628

Major Depressive Disorder

UNKNOWN NA

Pharmacotherapy and Psychotherapy for MDD After Remission on Psychology and Neuroimaging

NCT01831440

Depressive Disorder

UNKNOWN NA

Quality of Life and Its Related Factors of Patients With Major Depressive Disorder

NCT00172549

Depression

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a multi-center cross-sectional study. Patients with MDD who received medication treatment and achieved remission for at least 8 weeks will be enrolled. For all the participants, demographic information will be collected; clinical symptoms, cognitive function, occupational/study ability, and quality of life will be evaluated by using 17-items HAMD, PHQ-9, HAMA, PSQI, SHAPS, HCL-32, SDS, LEAPS, QOL-6, PFQ and THINC-it toolkit.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Major Depressive Disorder Remission

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MDD patients

No intervention.

treatment as usual

Intervention Type OTHER

No inervention. Treatment regime remains unchanged.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

treatment as usual

No inervention. Treatment regime remains unchanged.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Out-patients;
* Men or women aged between 16 and 50, with junior high school education or above;
* According to medical history, patients should be diagnosed with major depressive episode by two or above psychiatric doctors based on ICD-10 criteria;
* According to assessment, patients should meet the DSM-5 criteria for MDD when in past episodes;
* Patients received stable ant-depression medication treatment for at least 8 weeks before enrolment;
* 17-item HAMD total score ≤ 7;
* Willing to participate in this study, and sign an informed consent.

Exclusion Criteria

* HCL-32 total score \< 12;
* Diagnosed with bipolar disorder;
* Suffering from some serious physical diseases (e.g. moderate or severe brain injury, central nervous system diseases, or other unstable physical condition affecting the whole body) adversely affects the performance on neuropsychological test or rating scales;
* Received ECT in the past 6 months.

Minimum Eligible Age

16 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No